TuHURA BIOSCIENCES, INC./NV Convertible Preferred Stock, Shares Issued upon Conversion
TuHURA BIOSCIENCES, INC./NV (HURA) had Convertible Preferred Stock, Shares Issued upon Conversion of 0 shares as of 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Notes › Equity › Stockholders' Equity Note › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion · last filed 2020-11-12
- 2020-09-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
- 2020-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 25.00K shares.
- 2019-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 207.50K shares.
- 2018-06-30: Convertible Preferred Stock, Shares Issued upon Conversion 0.00 shares.
| Period end | Convertible Preferred Stock, Shares Issued upon Conversion |
|---|---|
| 2020-09-30 | 0.00 shares 10-Q · filed 2020-11-12 |
| 2020-06-30 | 25.00K shares 10-Q · filed 2020-11-12 |
| 2019-06-30 | 207.50K shares 10-K · filed 2020-09-18 |
| 2018-06-30 | 0.00 shares 10-K · filed 2019-09-09 |
| 2017-06-30 | 21.13K shares 10-K · filed 2018-09-24 |
| 2016-06-30 | 0.00 shares 10-K · filed 2017-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |